Jinjun Guo

850 total citations
48 papers, 589 citations indexed

About

Jinjun Guo is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Jinjun Guo has authored 48 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 21 papers in Hepatology and 13 papers in Molecular Biology. Recurrent topics in Jinjun Guo's work include Hepatitis B Virus Studies (24 papers), Hepatitis C virus research (19 papers) and Liver Disease Diagnosis and Treatment (13 papers). Jinjun Guo is often cited by papers focused on Hepatitis B Virus Studies (24 papers), Hepatitis C virus research (19 papers) and Liver Disease Diagnosis and Treatment (13 papers). Jinjun Guo collaborates with scholars based in China, United Kingdom and United States. Jinjun Guo's co-authors include Qingling Li, Ailong Huang, Xia Zhang, Bo Ning, Xiaoling Wu, Hongbin Zhang, Bo Liu, Zhenzhen Zhang, Ben C.B. Ko and Stephen S. Chung and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jinjun Guo

44 papers receiving 581 citations

Peers

Jinjun Guo

EPIDE

HEPAT

Mong-Liang Chen Taiwan

Haijing Fu China

Takemitsu Nagahata Japan

Sanglin Li China

Silvia Doratiotto Italy

Su‐Jun Li China

Emily Schonfeld United States

Yunlong Pan China

Hailing Yan United States

Mong-Liang Chen Taiwan

Jinjun Guo

269 ×1.0

252 ×1.4

EPIDE

151 ×0.9

174 ×1.3

HEPAT

42 ×0.6

Citations per year, relative to Jinjun Guo Jinjun Guo (= 1×) peers Mong-Liang Chen

Countries citing papers authored by Jinjun Guo

Since Specialization

Citations

This map shows the geographic impact of Jinjun Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinjun Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinjun Guo more than expected).

Fields of papers citing papers by Jinjun Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinjun Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinjun Guo. The network helps show where Jinjun Guo may publish in the future.

Co-authorship network of co-authors of Jinjun Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Jinjun Guo. A scholar is included among the top collaborators of Jinjun Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinjun Guo. Jinjun Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xie, Yuchen, Zhijun Chen, Lihua Lü, et al.. (2025). Tumor-derived C4BPA promotes macrophage M2-like polarization through C5a -C5aR1-STAT3 axis and drives gastric cancer progression. International Immunopharmacology. 168(Pt 1). 115830–115830.

Huang, Cheng-Fang, Jinjun Guo, Zhengtao Zhang, et al.. (2025). Indirect economic benefits of energy consumption changes under China's carbon neutrality goal. Energy. 317. 134692–134692. 3 indexed citations

Chen, Juan, et al.. (2024). The underlying mechanism and targeted therapy strategy of miRNAs cross-regulating EMT process through multiple signaling pathways in hepatocellular carcinoma. Frontiers in Molecular Biosciences. 11. 1378386–1378386. 3 indexed citations

Peng, Hong, et al.. (2024). Advancements in NMN biotherapy and research updates in the field of digestive system diseases. Journal of Translational Medicine. 22(1). 805–805. 10 indexed citations

Peng, Hong, et al.. (2023). Activin and Hepatocyte Growth Factor Promotes Colorectal Cancer Stemness and Metastasis through FOXM1/SOX2/CXCR4 Signaling. Gut and Liver. 18(3). 476–488. 2 indexed citations

Peng, Hong, et al.. (2022). Sequential Treatment with Activin and Hepatocyte Growth Factor Induces FOXM1 to Promote Colorectal Cancer Liver Metastasis. Canadian Journal of Gastroenterology and Hepatology. 2022. 1–15. 2 indexed citations

Zhang, Jinjun, Yi Xu, Jialiang Liu, et al.. (2021). Epidemiological and clinical characteristics of imported cases of COVID-19: a multicenter study. BMC Infectious Diseases. 21(1). 406–406. 5 indexed citations

Chen, Peng, et al.. (2020). Epidemiological and clinical characteristics of 136 cases of COVID-19 in main district of Chongqing. Journal of the Formosan Medical Association. 119(7). 1180–1184. 18 indexed citations

Chen, Hong, et al.. (2017). [Association of HLA-DQ and IFNL4 polymorphisms with hepatitis B virus infection and clearance].. PubMed. 25(7). 506–511. 1 indexed citations

10.

Li, Qingling, et al.. (2017). Association of HLA-DQ and IFNL4 polymorphisms with susceptibility to hepatitis B virus infection and clearance.. SHILAP Revista de lepidopterología. 15(4). 532–9. 11 indexed citations

11.

Zhang, Yan, et al.. (2017). Retinoid X Receptor α-Dependent HBV Minichromosome Remodeling and Viral Replication. Annals of Hepatology. 16(4). 501–509. 5 indexed citations

12.

Peng, Xiaozhong, et al.. (2015). Association of genetic polymorphisms in CD8 + T cell inhibitory genes and susceptibility to and progression of chronic HBV infection. Infection Genetics and Evolution. 36. 467–474. 12 indexed citations

13.

Yan, Zhang, Song He, Qingling Li, & Jinjun Guo. (2013). Dynamics of hepatitis B virus resistance substitutions correlates with virological response in lamivudine-refractory patients with entecavir rescue monotherapy. Virus Research. 177(2). 156–162. 4 indexed citations

14.

Li, Qingling, et al.. (2013). Complexity and diversity of hepatitis B virus quasispecies: Correlation with long-term entecavir antiviral efficacy. Antiviral Research. 99(3). 312–317. 9 indexed citations

15.

Li, Qingling, et al.. (2013). Dynamics of lamivudine-resistant hepatitis B virus strains in patients with entecavir rescue therapy. Virus Genes. 47(1). 1–9. 10 indexed citations

16.

Luo, Li, Shu Chen, Qian Gong, et al.. (2012). Hepatitis B virus X protein modulates remodelling of minichromosomes related to hepatitis B virus replication in HepG2 cells. International Journal of Molecular Medicine. 31(1). 197–204. 11 indexed citations

17.

Gong, Qian, Shu Chen, Jinjun Guo, et al.. (2011). Chromosome Remodeling Related to Hepatitis B Virus Replication in HepG2 Cells. DNA and Cell Biology. 30(6). 347–354. 15 indexed citations

18.

Zhang, Hongbin, Zhenzhen Zhang, Xia Zhang, et al.. (2009). Down-regulated miR-9 and miR-433 in human gastric carcinoma. Journal of Experimental & Clinical Cancer Research. 28(1). 82–82. 159 indexed citations

19.

Hu, Jieli, Jing Cui, Xiaoyan Deng, et al.. (2009). A new strategy for constructing in vitro replication-competent 1.3 copies of hepatitis B virus genome. Journal of Virological Methods. 161(1). 63–69. 7 indexed citations

20.

Guo, Jinjun, et al.. (2008). Dynamics of hepatitis B virus resistance to entecavir in a nucleoside/nucleotide-naïve patient. Antiviral Research. 81(2). 180–183. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact